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NMDA receptors (NMDARs) play a crucial role in neuronal development, synaptic plasticity, and excitotoxicity; therefore, regulation of
NMDAR function is important in both physiological and pathological conditions. Previous studies indicate that the NMDAR-mediated
synaptic current decay rate increases during development because of a switch in receptor subunit composition, contributing to develop-
mental changes in plasticity. To test whether NMDAR desensitization also changes during development, we recorded whole-cell NMDA-
evoked currents in cultured rat hippocampal neurons. We found that glycine-independent desensitization of NMDARs decreases during
development. This decrease was not dependent on a switch in subunit composition or differential receptor sensitivity to agonist-, Ca 2-,
or Zn 2-induced increase in desensitization. Instead, several lines of evidence indicated that the developmental decrease in desensiti-
zation was tightly correlated with synaptic localization of the receptor, suggesting that association of NMDARs with proteins selectively
expressed at synapses in mature neurons might account for developmental alterations in desensitization. Accordingly, we tested the role
of interactions between PSD-95 (postsynaptic density-95) and NMDARs in regulating receptor desensitization. Overexpression of PSD-95
reduced NMDAR desensitization in immature neurons, whereas agents that interfere with synaptic targeting of PSD-95, or induce
movement of NMDARs away from synapses and uncouple the receptor from PSD-95, increased NMDAR desensitization in mature
neurons. We conclude that synaptic localization and association with PSD-95 increases stability of hippocampal neuronal NMDAR
responses to sustained agonist exposure. Our results elucidate an additional mechanism for differentially regulating NMDAR function in
neurons of different developmental stages or the response of subpopulations of NMDARs in a single neuron.
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Introduction
Fast excitatory synaptic transmission in the mammalian CNS is
mediated predominantly by three types of ionotropic glutamate
receptors, including AMPA, NMDA, and kainate receptors
(Monaghan et al., 1989). Extensive studies have established that
NMDA receptors (NMDARs) play a crucial role in neuronal de-
velopment and synaptic plasticity and that overactivation of
NMDARs leads to excitotoxicity (Dingledine et al., 1999).
Activation of NMDARs is limited by a number of processes,
including peak current rundown, Ca 2-dependent inactivation,
glycine-dependent desensitization, and glycine-independent de-
sensitization (for review, see McBain and Mayer, 1994; Dingle-
dine et al., 1999). Regulation of NMDAR activity by these pro-
cesses is believed to be important in both physiological and
pathological conditions. For example, manipulations that sup-
press Ca 2-dependent rundown of NMDARs enhance NMDA-
or glutamate-induced excitotoxicity (Furukawa et al., 1995;
Abdel-Hamid and Baimbridge, 1997; Furukawa et al., 1997),
whereas conditions that promote Ca 2-dependent rundown
protect from glutamate- or oxygen– glucose deprivation-induced
excitotoxicity (Furukawa et al., 1995; Sattler et al., 2000). As well,
NMDAR desensitization during repetitive firing contributes to
shaping synaptic responses and neuronal activity (Tong et al.,
1995; Jones and Westbrook, 1996). Rapid desensitization of non-
NMDARs is protective against AMPA-induced excitotoxicity
(Zorumski et al., 1990; May and Robison, 1993; Brorson et al.,
1995; Raymond et al., 1996). Desensitization and inactivation of
NMDARs may also be protective during a sustained glutamate
insult by limiting calcium influx.
NMDARs are tetrameric complexes of two NR1 subunits in
combination with NR2A, 2B, 2C, 2D, or NR3 (Dingledine et al.,
1999). NMDAR glycine-independent desensitization, which is
determined by two domains flanking the putative agonist-
binding domain in the N terminus of the NR2 subunit (Krupp et
al., 1998; Villarroel et al., 1998), is subtype dependent. Desensi-
tization of NR1/NR2A is greater than NR1/NR2B (Krupp et al.,
1996), whereas NR1/NR2C and NR1/NR2D do not desensitize at
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all when expressed in heterologous cells (Krupp et al., 1998; Vil-
larroel et al., 1998). Moreover, this form of desensitization is
regulated by calcineurin (Tong and Jahr, 1994; Tong et al., 1995),
which causes a time-dependent increase in desensitization
(Sather et al., 1992; Tong and Jahr, 1994; Tong et al., 1995)
through direct dephosphorylation of serine residues in the NR2
C-terminal tail (Krupp et al., 2002). Zinc also regulates glycine-
independent desensitization via an allosteric interaction between
the zinc-binding and ligand-binding domains (Zheng et al.,
2001).
Here we report a developmental decrease in glycine-
independent desensitization of NMDARs in cultured hippocam-
pal neurons. Although expression of the two major NR2 subunits
in the hippocampal region, 2A and 2B, is developmentally regu-
lated, with 2B subunits dominating early and 2A subunits replac-
ing 2B later in development (Williams et al., 1993; Hollmann and
Heinemann, 1994; Monyer et al., 1994; Zhong et al., 1994; Li et
al., 1998; Rao et al., 1998; Stocca and Vicini, 1998; Tovar and
Westbrook, 1999; Barria and Malinow, 2002), the change in de-
sensitization was not dependent on the switch in subunit compo-
sition, nor was it dependent on altered agonist, Ca 2, or zinc
sensitivity. Instead, we found that the progressive decrease in
extent of glycine-independent desensitization during develop-
ment correlated well with increasing localization of NMDARs at
synapses and their association with PSD-95 (postsynaptic
density-95), a scaffolding protein highly expressed in the PSD.
We propose that the coupling of NMDARs with other signaling
proteins via PSD-95 that occurs at synapses mediates the devel-
opmental change in desensitization.
Materials and Methods
Primary neuronal cultures and transfection. Embryonic hippocampal cul-
tures were prepared as described previously (Li et al., 2002). Briefly, rat
hippocampi were dissected from 17- to 18-d-old embryos and subse-
quently dissociated using papain and trituration with fire-polished glass
pipettes. Cells were plated in Neurobasal medium supplemented with
B27 and grown on poly-D-lysine-coated coverslips at a density of300 –
400 cells/mm 2. Cultures were maintained in a humidified atmosphere
with 5%CO2. One-half of the medium was changed twice every week.
Neurons were transfected with either PSD-95– green fluorescent protein
(GFP) or GFP construct by lipid-mediated gene transfer kit (N-[1-(2,3-
dioleoyloxy)propyl]- N, N,N-trimethylammonium methyl-sulfate) as
described previously (Craven et al., 1999) or by Effectene Transfection
Reagent (Qiagen, Hilden, Germany). Briefly, neurons were transfected at
2– 4 d in vitro (DIV). For transfection of eight wells (in a 24-well plate), 2
g of DNA was mixed with 150 l of EC buffer and 16 l of enhancer.
After 5 min of incubation at room temperature, 25 l of Effectene was
added. The resulting solution was mixed gently and incubated for an-
other 10 min at room temperature. Fresh Neurobasal medium (1 ml) was
then added to the solution. A total of 135 l of this DNA-Effectene mix
solution was added into each well of neurons containing 200 l of me-
dium and incubated at 37°C for 3–5 hr. DNA–Effectene mix solution was
then replaced with 0.5 ml of medium (containing 50% conditioned and
50% fresh medium) for each well. Neurons were used for patch-clamp
recording 2–3 d after transfection.
Microisland cultures were made as described previously (Bekkers and
Stevens, 1991; Li et al., 2002). Briefly, glass coverslips were coated with
0.15% agarose and allowed to dry. A solution of poly-D-lysine (0.5 mg/
ml) and collagen (1.9 mg/ml; Upstate Biotechnology, Waltham, MA) was
then sprayed on the agarose background to form microdots. After growth
of the glial feeder layers on the microdots, the CA1–CA3 region of hip-
pocampi from postnatal day 0 –3 rats were removed, enzymatically (20
U/ml papain) and mechanically dissociated, and then plated. Cells were
grown in a solution based on Neurobasal A medium (Invitrogen, Burl-
ington, Ontario, Canada) supplemented with 2.5% fetal calf serum, 2%
B27, 20 mM glucose, 0.5 mM glutamine, and 0.2% penicillin–streptomy-
cin stock.
HEK293 cell culture and transfection. HEK293 cells (CRL 1573; Amer-
ican Type Culture Collection, Rockville, MD) were maintained as we
described previously (Chen et al., 1997). Cells were transfected using the
calcium phosphate precipitation method (Chen et al., 1997) with a total
of 12 g of plasmid DNA/10 cm plate. Cells were transfected with equal
amounts of cDNAs encoding NR1–1a, NR2 (A or B), and GFP to allow
for identification of transfected cells during recording.
Electrophysiology. Neurons from embryonic rat hippocampal cultures
were used for recording at 4 –7 DIV, 10 –11 DIV, or13 DIV. Autaptic
cultures were used for recording at 11–14 DIV. Patch-clamp recording in
the whole-cell mode was performed using either the nystatin perforated-
patch method to maintain intracellular contents, as described previously
(Li et al., 2002), or conventional whole-cell patch-clamp recording
method (Hamill et al., 1981). For the conventional whole-cell recording,
the electrode solution contained 115 mM Cs-methanesulfonate, 10 mM
HEPES, 20 mM K2-creatine phosphate, 50 U/ml creatine phosphokinase,
4 mM MgATP, and 10 mM BAPTA, pH 7.26 (KOH), 310 mOsm. For
recording on autaptic neurons, the electrode solution contained 112.5
mM K-methanesulfonate, 8 mM NaCl, 5 mM MgATP, 20 mM HEPES, 0.2
mM BAPTA, 20 mM K2-creatine phosphate, and 50 U/ml creatine phos-
phokinase, pH 7.2.
The cells were continuously superfused with the external recording
solution. For HEK293 cells, the external recording solution contained the
following (in mM): 145 NaCl, 5.4 KCl, 11 glucose, 2 CaCl2, and 10
HEPES, pH 7.3. For neurons the external recording solution contained
the following (in mM): 167 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 2 CaCl2,
and 0 or 1 MgCl2, pH 7.3 (325 mOsm). TTX (300 nM), strychnine (2M),
and glycine (30 or 100 M as indicated) were added just before use. TTX
was omitted for autaptic culture recording. As described previously
(Chen et al., 1997), agonist or drug application was gravity fed to the cells
using a -tube. NMDA (100 M or 1–2 mM as indicated) was included
only in the agonist side of the -tube, which contained the same solution
as the external recording solution, except sometimes with reduced CaCl2
concentration as indicated (0.2 mM CaCl2 for conventional whole-cell
recording; 0 mM CaCl2 plus 100 M EGTA with 1 mM MgCl2 for nystatin
patch recording). For recording on autaptic neurons, EPSCs were evoked
by depolarizing the cells from65 to 0 mV for 1.5 msec, and the whole-
cell responses were evoked by applying 1 mM NMDA in the external
solution in which CaCl2 was replaced with 1 mM SrCl2 to minimize
Ca 2-dependent inactivation (Legendre et al., 1993; Krupp et al., 1996).
All other drugs, when used as indicated, were included in both the con-
trol and agonist side of the -tube. Rapid switching between the two
solutions was achieved by computer-controlled solenoid-driven valves.
The recording protocol consisted of 10 sec agonist applications at a rate
of one per minute, unless otherwise indicated.
All recordings were made in voltage-clamp mode. Data were acquired
using the Axopatch 200B patch-clamp amplifier (Axon Instruments,
Foster City, CA). Currents were filtered at 5 kHz and digitized at 10 kHz.
pClamp 6.1 or 8.1 software (Axon Instruments) was used for data acqui-
sition and analysis. Access resistance and cell capacitance were moni-
tored by applying a brief, 5 mV hyperpolarizing voltage step just before
each agonist application (Li et al., 2002). The series resistance was com-
pensated 60 –70%. The membrane holding potential was 70 mV (for
nystatin patch recording) or 65 mV (for conventional whole-cell re-
cording) when Mg 2was not present in the recording solutions and was
40 mV when 1 mM Mg 2 was present.
Immunocytochemistry and quantification. To characterize the subcel-
lular localization of NMDARs and the expression pattern of overex-
pressed PSD-95–GFP in cultured hippocampal neurons, cells were dou-
ble labeled with antibodies against the presynaptic marker synaptophysin
and NR1, or GFP and NR1, or GFP and PSD-95. Briefly, neuronal cul-
tures were fixed with methanol at20°C for 10 min. After washing with
PBS, the cells were incubated with 1% BSA for 30 min. Primary antibod-
ies, including mouse monoclonal NR1 antibody (1:500; Chemicon, Te-
mecula, CA), rabbit polyclonal synaptophysin antibody (1:1000; Zymed
Laboratories, San Francisco, CA), mouse monoclonal PSD-95 (5 g/ml;
Chemicon), chicken (1:2000; Chemicon) or rabbit (1:100; Affinity
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BioReagents, Golden, CO) GFP antibodies were then incubated with the
cultures at room temperature for 1 hr. After washing with PBS, the cul-
tures were further incubated with green fluorescent anti-rabbit, mouse,
or chicken (Alexa 488; 1:1000; Molecular Probes, Eugene, OR) and red
fluorescent anti-mouse or rabbit (Cy3; 1:200; Jackson ImmunoResearch,
West Grove, PA) secondary antibodies at room temperature for 1 hr.
Images were acquired using a CCD camera affixed to a Zeiss
(Oberkochen, Germany) inverted microscope with AxioVision software
and displayed in Adobe Photoshop 5.5 (Adobe Systems, San Jose, CA).
To quantify the synaptic localization of NMDARs in different conditions,
we counted the number of synaptic receptor clusters per dendritic length
as described previously (Crump et al., 2001). Briefly, images were ex-
ported into Northern Eclipse (Empix Imaging, Missasauga, Ontario,
Canada) and custom-written software routines (O. Prange and A. E.
El-Husseini, unpublished observations) were applied for image analysis.
Only puncta with intensity at least twofold greater than the diffuse den-
dritic staining were chosen. Synaptic NMDAR clusters were defined by
overlap with synaptophysin-positive puncta and counted per dendritic
length. The resulting data were analyzed with Origin software (Microcal
Software, Northampton, MA). For quantification, 5–10 neurons from
two to three different batches of cultures and experiments for each con-
dition were randomly chosen on the basis of healthy morphology.
Coimmunoprecipatition. Sister hippocampal neuronal cultures of
14 –17 DIV in 10 cm dishes were treated with 2-bromopalmitate, vehicle,
or picrotoxin (PTX) as indicated in Results and then scraped into a
PBS-based harvest buffer containing 1 mM EGTA, 1 mM EDTA, 1 mM
PMSF, 2g/ml aprotinin, 20g/ml pepstatin A, and 20g/ml leupeptin.
For one 10 cm dish, 1 ml of harvest buffer was used. After centrifugation,
the pellet was lysed and solubilized in harvest buffer containing 0.1% SDS
and 0.8% Triton X-100 (0.5 ml final volume). One-tenth of the lysate was
reserved for input loading, and the remainder was incubated with
protein-A and protein-G beads, each 20l, for 1 hr at 4°C to remove any
proteins that nonspecifically bind to the beads. After brief centrifugation,
the supernatant was reserved and incubated with 10 g of rabbit poly-
clonal anti-NR2A antibody (Upstate Biotechnology) for 1 hr at 4°C.
Protein-A and protein-G beads, each 30 l, were then added to the solu-
tion and incubated at 4°C for 1 hr. The beads were washed three times
with a Tris wash buffer containing 50 mM Tris, pH 7.4, 150 mM NaCl, 1
mM EDTA, 1 mM EGTA, and 1% Triton X-100. The proteins were eluted
from the beads and denatured by boiling in loading buffer for 5 min and
then resolved by SDS-PAGE as described previously (Chen et al., 1999).
Proteins from each of the different conditions (vehicle,
2-bromopalmitate, and PTX) were loaded to the same gel. After transfer,
membranes were probed with antibodies against the NMDAR NR2A
subunit (1:1000 of affinity-purified rabbit polyclonal; a generous gift
from Dr. Richard Huganir, Johns Hopkins Medical School, Baltimore,
MD) and PSD-95 (mouse monocolonal; 5 g/ml; Chemicon). The re-
sulting blots were quantified by densitometric analysis (Li et al., 2002).
The amount of PSD-95 coimmunoprecipated with NR2A was deter-
mined as the PSD-95 to NR2A band-density ratio.
Materials. Genistein, bpV(phen), protein kinase inhibitor (PKI), and
KN93 were from Calbiochem-Novabiochem (San Diego, CA). Latrun-
culin A or B was from Biomol (Plymouth Meeting, PA).
2-Bromopalmitate was a gift from Dr. A. E. El-Husseini (University of
British Columbia, Vancouver, British Columbia, Canada). All other
chemicals were purchased from Sigma (St. Louis, MO). The PSD-95–
GFP and PSD-95(C3,5S)–GFP constructs were gifts from Dr. D. S. Bredt
(University of California at San Francisco, San Francisco, CA) and were
described previously (Craven et al., 1999). NR1–1a (Dingledine et al.,
1999) and NR2B cDNAs were gifts from Dr. Nakanishi (Kyoto Univer-
sity, Kyoto, Japan), and NR2A (1) was a gift from Dr. Mishina (Tokyo
University, Tokyo, Japan). These constructs were described previously
(Raymond et al., 1996; Chen et al., 1997). Tissue culture reagents were
obtained from Invitrogen.
Data analysis. Results are presented as mean  SE. Sets of different
results were compared using one-way ANOVA or Student’s t test as
appropriate, and significant differences were determined at the 95% con-
fidence intervals. Three to 10 responses of each cell were averaged for
estimation of steady-state to peak current (Iss/Ip) ratio. In some cases,
only the first response was measured because the Iss/Ip ratio was quite
stable over time during our recording conditions.
Results
Neuronal NMDARs show developmental change in
desensitization independent of subunit composition
NMDAR glycine-independent desensitization is involved in lim-
iting receptor activation during repeated or sustained exposure to
glutamate (McBain and Mayer, 1994; Tong et al., 1995). To iden-
tify factors regulating this process in cultured hippocampal neu-
rons, we measured desensitization of NMDAR currents in re-
sponse to 10 sec applications of 100M NMDA in the continuous
presence of 30 M glycine, using the nystatin perforated-patch
recording technique to preserve intracellular contents and en-
dogenous signaling mechanisms. Because NMDAR subunit com-
position is an important determinant of receptor function and
modulation, we began by comparing desensitization of 2A-
containing NMDARs (recorded from 13 DIV neurons bathed
in the NR1/NR2B-subtype-selective antagonist ifenprodil; this
population would include both NR1/NR2A and NR1/NR2B/
NR2A) to that of NMDARs in 4 –7 DIV neurons, which mainly
express NR1/NR2B, and to 2B-subtype NMDARs isolated phar-
macologically in 13 DIV neurons. We showed previously that
ifenprodil blocked 76% of the NMDAR-mediated current re-
corded from 4 –7 DIV neurons (Li et al., 2002), suggesting that
those neurons indeed mainly express 2B-subtype NMDARs, as
reported by others (Tovar and Westbrook, 1999). To isolate 2B-
subtype NMDARs in13 DIV neurons, we used a combination
of ()-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-
5,10-imine maleate (MK-801) and ifenprodil (Li et al., 2002). In
the presence of both ifenprodil and MK-801, repeated applica-
tions of NMDA resulted in selective activation of 2A-containing
receptors that were then irreversibly blocked by MK-801. We
then removed ifenprodil and MK-801 and washed extensively
with control solution to recover the 2B-subtype NMDAR cur-
rent. Strikingly, the 2B-subtype NMDARs in both 4 –7 DIV and
13 DIV neurons showed a higher degree of glycine-
independent desensitization compared with 2A-containing
NMDARs in 13 DIV neurons when recorded in 2 mM Ca 2
(Fig. 1A). To minimize differences in apparent desensitization
attributable to Ca 2-dependent processes, we made recordings
in the absence of external Ca 2 and at positive holding potentials
(to minimize any residual Ca 2 entry). Also, because the 2B-
subtype is more sensitive to agonist than the 2A-subtype of
NMDARs (Dingledine et al., 1999) and NMDA is less potent than
glutamate (Sather et al., 1992), we repeated our experiment using
2 mM NMDA to saturate both subtypes of receptors. Under these
conditions, desensitization was still markedly more extensive for
2B-subtype NMDARs in 4 –7 DIV neurons than for 2A-
containing NMDARs in13 DIV (Fig. 1B). These data indicate
that Ca 2-dependent processes and differential sensitivity to
NMDA cannot explain the difference in NMDAR
desensitization.
To define the macroscopic kinetics of the NMDAR response
more precisely and further investigate the factors regulating dif-
ferences in neuronal NMDAR desensitization during develop-
ment, we also used conventional whole-cell recording. In these
experiments, the external Ca 2was kept low (0.2–1 mM), and the
intracellular pipette solution contained 10 mM BAPTA to mini-
mize Ca 2-dependent inactivation (Zheng et al., 2001). Also,
saturating concentrations of NMDA (1 mM) and glycine (100
M) were used to isolate glycine-independent desensitization
from other mechanisms. Under these conditions, neuronal
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NMDARs showed a clear decrease in desensitization (increase in
Iss/Ip) during development (Fig. 2A). The Iss/Ip ratio was 34 3%
(n 25), 47 5% (n 12), and 74 2% (n 30) for neurons
of 4 –7, 10 –11, and 14 DIV, respectively ( p  0.0001 by one-
way ANOVA followed by Bonferroni’s multiple comparisons
test). The decrease in desensitization with development was not
attributable to a decrease in NMDA-evoked current amplitude,
because mean peak current amplitude was much smaller for im-
mature neurons (2234 248 pA; n 12) than for mature neu-
rons (5802 512 pA; n 16).
Zinc in the submicromolar range has been shown to increase
NMDAR desensitization for recombinant receptors expressed in
HEK293 cells (Chen et al., 1997; Zheng et al., 2001). Because salt
solutions often contain submicromolar zinc as a result of con-
tamination (Paoletti et al., 1997), we wondered whether a change
in sensitivity to ambient zinc during development might explain
our results. To test this possibility, we added 2 M N,N,N,N-
tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN) to chelate
ambient zinc in the external solution (Paoletti et al., 1997). In
contrast to results for recombinant NMDARs in HEK293 cells,
chelation of zinc did not decrease the desensitization of hip-
pocampal neuronal NMDARs at any developmental stage (Fig. 2,
compare Iss/Ip for TPEN condition in B with that in A), and the
progressive increase in Iss/Ip with development was preserved.
Thus, the developmental change in desensitization of neuronal
NMDARs is not attributable to altered receptor sensitivity to
zinc.
To determine whether NR2A-containing NMDARs also un-
dergo the developmental change in desensitization, we repeated
the experiments in the presence of the NR2B-subtype-selective
inhibitor ifenprodil (3M). Although ifenprodil increased desen-
sitization at each developmental stage (all Iss/Ip ratios were
lower), the developmental decrease in desensitization was still
apparent (Fig. 2B). The Iss/Ip ratio was 7 3% (n 5), 25 2%
(n 5), and 43 3% (n 16) for neurons of 4 –7, 10 –11, and
14 DIV, respectively ( p  0.0001 by one-way ANOVA fol-
lowed by Bonferroni’s multiple comparisons test). An increase in
NMDAR desensitization in the presence of ifenprodil has also
been reported for recombinant receptors expressed in HEK293
cells (Zheng et al., 2001). In our experiments, increased desensi-
tization in the presence of ifenprodil was abolished for all devel-
opmental stages examined by addition of 2 M TPEN (Fig. 2B),
suggesting that NMDARs are more sensitive to ambient zinc in
the presence of ifenprodil. Because relative differences in desen-
Figure 1. Neuronal 2B-subtype NMDARs show more glycine-independent desensitization
than 2A-containing NMDARs. A, Left, Representative responses mediated by NMDARs in a 6 DIV
neuron or a 15 DIV neuron in the presence of 10M ifenprodil, in response to 100M NMDA (30
M glycine) in the presence of 2 mM calcium. Right, Pooled data showing that NMDARs in 4 –7
DIV neurons or 2B-subtype NMDARs in13 DIV neurons have higher degree of desensitization
than 2A-containing NMDARs in13 DIV neurons. VH of 65 mV. Recordings were made from
n 12, 12, and 7 different neurons for the three different groups:13 DIV, 2A; 4 –7 DIV; and
13 DIV, 2B, respectively. B, Same as A, except Ca 2 was replaced by 1 mM Mg 2, holding
potential was40 mV, [NMDA] was 2 mM, and [glycine] was 100M. All recordings were made
using the nystatin perforated recording technique.
Figure 2. Developmental change in NMDAR desensitization is independent of subunit com-
position and zinc sensitivity. A, Left, Representative responses of NMDARs in 6, 11, and 16 DIV
neurons in response to 1 mM NMDA (100 M glycine) in 0.2 mM extracellular Ca 2. Electrode
solution contained 10 mM BAPTA. Recordings were made using conventional whole-cell patch-
clamp technique with VH of65 mV. Currents were normalized for comparison of desensitiza-
tion. Right, Quantification of desensitization showing a developmental change. B, Recording
conditions were identical to A, except that 3M ifenprodil (IFN) and/or 2M TPEN was added
to external solution. Inclusion of 2 M TPEN to remove ambient zinc in recording solution did
not significantly change NMDAR desensitization compared with control condition ( p 0.05 at
each development stage compared with data shown in A). Ifenprodil increased desensitization
(left and right panels), an effect reversed by inclusion of TPEN (middle and right panels), but the
trend toward decreased desensitization with maturation was preserved. Recordings were made
from the following: n 5, 12, and 5 different neurons of 4 –7, 10 –11, and14 DIV, respec-
tively, for ifenprodil plus TPEN; n 6, 4, and 5 of 4 –7, 10 –11, and14 DIV, respectively, for
TPEN alone; and n 5, 5, and 16 of 4 –7, 10 –11, and14, respectively, for ifenprodil alone.
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sitization were still observed in the presence of ifenprodil, we
concluded that developmental changes in neuronal NMDAR de-
sensitization were not dependent on a switch in subunit
composition.
NMDAR desensitization is regulated by receptor
subcellular localization
One major difference between NMDARs in 4 –7 DIV and those in
13 DIV neurons is their subcellular localization. NMDARs ex-
pressed in immature neurons are mainly extrasynaptic, whereas
the majority are localized to synapses in more mature neurons (Li
et al., 1998; Rao et al., 1998; Tovar and Westbrook, 1999). It is
possible that synaptic localization renders NMDARs more resis-
tant to desensitization. This explanation would also be consistent
with our results showing that 2B-subtype NMDARs in13 DIV
neurons desensitize more extensively than 2A-subtype NMDARs
(Fig. 1A), because the majority of NR2A subunits are incorpo-
rated into synapses whereas NR2B subunits continue to predom-
inate at extrasynaptic sites (Li et al., 1998; Stocca and Vicini, 1998;
Tovar and Westbrook, 1999; Barria and Malinow, 2002; Li et al.,
2002).
To test whether extrasynaptic NMDARs desensitize more ex-
tensively than synaptic NMDARs, we chronically treated 13
DIV neurons with PTX, which decreases inhibitory input leading
to robust bursting (Murphy et al., 1992). As a result, NMDAR
activation is chronically increased, eventually leading to a de-
creased number of synaptic NMDARs (Crump et al., 2001).
Treatment with 100 M PTX for 1 week indeed depleted
NMDARs from synapses (and from the dendrite, in general) in
13 DIV neurons, as assessed by immunocytochemical colocal-
ization with synaptophysin (Fig. 3A,B), and also markedly in-
creased NMDAR desensitization (Fig. 3C). Note that treatment
with PTX also disrupted the interaction between NMDARs and
PSD-95 (see Fig. 5A and text below).
To test within a single cell whether extrasynaptic NMDARs
desensitize more readily than synaptic NMDARs, we used single-
cell microisland cultures (Bekkers and Stevens, 1991; Li et al.,
2002) to directly compare extrasynaptic NMDARs with total sur-
face NMDARs. Neurons with autaptic synapses in 11–14 DIV
cultures were stimulated with short depolarizations to generate
action potentials in the presence of MK-801 (20M). Under these
conditions, synaptic NMDARs were selectively activated and
blocked after 57  6 stimuli (n  7) (Fig. 4A). Desensitization
(assessed by exogenous application of NMDA) before and after
blockade of the synaptic NMDARs in a representative neuron is
shown in Figure 4A (middle). Responses mediated by extrasyn-
Figure 3. Synaptic localization of NMDARs increases with development and is decreased by picrotoxin treatment. A, Representative photomicrographs of double labeling of NR1 (red) and
synaptophysin (green) in cultured hippocampal neurons of 7 DIV, 19 DIV chronically treated with PTX, and 19 DIV treated with vehicle (control), respectively. Scale bars, 10m. White boxes outline
regions shown at higher gain directly below each photomicrograph. B, Quantification of the number of synaptic NR1 clusters per 100m dendrite for different conditions (19 DIV, control, 78 9;
19 DIV, PTX, 19 3; 7 DIV, 36 6; **p 0.01, ***p 0.001 compared with control condition). C, Recordings were made, as described in Figure 2 A, from13 DIV neurons treated with vehicle
alone (13 DIV) or picrotoxin (13 DIV, PTX). Iss /Ip , 74 2 and 44 2%, n 30 and 12, for control and PTX group, respectively; ***p 0.0001.
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aptic NMDARs (spared from activity-dependent MK-801 block)
clearly showed a higher degree of desensitization compared with
whole-cell responses mediated by the combined pool of synaptic
and extrasynaptic NMDARs (Fig. 4A, middle and right). Ap-
proximately 60% of the NMDARs in these autaptic neurons were
synaptic, because the extrasynaptic NMDAR-mediated response
was 39  4% of the initial whole-cell response (n  7). On the
other hand, when the same number of synaptic stimuli was ap-
plied in the absence of MK-801, there was no change in NMDA-
evoked current desensitization (Fig. 4B), indicating that the in-
crease in desensitization was not a nonspecific effect of repeated
synaptic activation or attributable to prolonged whole-cell
recording.
Effect of PSD-95 on NMDAR desensitization
Unlike extrasynaptic NMDARs, synaptic NMDARs are directly
associated with a variety of proteins that are enriched in the PSD
compartment, including the major scaffolding protein PSD-95
(Kornau et al., 1995; Niethammer et al., 1996). To determine
whether PSD-95 can play a role in mediating regulation of
NMDAR desensitization, we first treated mature (13 DIV) neu-
rons with 2-bromopalmitate, a palmitoylation inhibitor that can
disperse PSD-95 away from synapses without affecting synaptic
clustering of NMDARs (El-Husseini et al., 2002). To confirm that
treatment with 2-bromopalmitate results in dissociation of
NMDARs from PSD-95, we treated neurons with 100 M
2-bromopalmitate for 10 hr and then examined the interaction
between NMDARs and PSD-95 using immunoprecipitation with
an anti-NR2A antibody. As expected, 2-bromopalmitate treat-
ment significantly decreased the amount of PSD-95 coimmuno-
precipitated with NR2A compared with control (vehicle-only
treatment) (Fig. 5A,B). Chronic treatment with picrotoxin also
markedly decreased the interaction of NMDARs with PSD-95
(Fig. 5A) (n  2 different experiments), consistent with the im-
munocytochemical data (Fig. 3A,B). Incubation with 100 M
2-bromopalmitate for 6 –10 hr before recording significantly in-
creased NMDAR desensitization (Fig. 5C). On the other hand,
treatment with latrunculin B (5 M) to depolymerize F-actin,
which disperses both NMDARs and PSD-95 away from synapses
in which they remain stably associated (Allison et al., 1998; Sattler
et al., 2000), had no effect on desensitization (Fig. 5C); similarly,
latrunculin A had no effect, and data were combined. These re-
sults suggest that association with PSD-95 and not necessarily
Figure 4. Extrasynaptic NMDARs show more extensive desensitization than synaptic
NMDARs. A, Left, NMDAR-mediated synaptic responses were recorded from an autaptic neuron
in the presence of 20M MK-801. CNQX (5M) and 2 mM Ca 2were present in the extracellular
recording solution. Standard whole-cell voltage clamp was used. First, 10th, 20th, and 44th
responses in the presence of MK-801 are shown. Middle, Responses of the same neuron to 1 mM
NMDA (100 M glycine) before and after blockade of synaptic NMDARs. Ca 2 was replaced
with 1 mM Sr 2. Currents were normalized for comparison of desensitization. VH of65 mV.
Right, Quantification showing that extrasynaptic NMDAR-mediated responses had higher de-
gree of desensitization than whole-cell responses. Iss /Ip , 412 and 714% for extrasynaptic
and whole-cell responses, respectively; n 8; ***p 0.0001; paired t test. B, Same as A,
except MK-801 was omitted during the synaptic activation. Left, First, 10th, 20th, and 60th
synaptic NMDAR responses are shown. Middle, Responses of the same neuron to 1 mM NMDA
(100M glycine) before and after synaptic activation. Currents were normalized for comparison
of desensitization. Right, Quantification showing no change in NMDA-evoked current desensi-
tization after repeated activation of synaptic NMDARs ( p 0.05; n 6; paired t test).
Figure 5. Inhibition of palmitoylation disrupts the interaction between NMDARs and PSD-95
and increases NMDAR desensitization in mature neurons. A, Representative Western blot show-
ing coimmunoprecipation of NR2A and PSD-95. Sister cultures of13 DIV were treated with
different conditions, including PTX, 2-bromopalmitate, or control (vehicle only). An anti-NR2A
antibody was used for immunoprecipitation (IP), and the resulting blots were probed with both
NR2A and PSD-95 antibodies. B, The band density of PSD-95 and NR2A were quantified using
densitometry and presented as the PSD-95 to NR2A band density ratio (**p 0.01 by paired t
test; n  5 separate experiments with different batches of neurons). C, Treatment with
2-bromopalmitate to disperse PSD-95, but not treatment with latrunculin to depolymerize
F-actin or with vehicle only (control), increased NMDAR desensitization in13 DIV neurons.
Iss /Ip was 49 2 and 68 3%, n 5 and 12 different neurons for 2-bromopalmitate and
control, respectively; ***p  0.001 by unpaired t test. Iss /Ip was 70  5%, n  11 for
latrunculin-treated neurons; p0.05 compared with control. Recording conditions were iden-
tical to those described in Figure 2 A.
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synaptic localization is required to make NMDARs in mature
neurons more resistant to desensitization.
To further test the effects of PSD-95, we overexpressed in
immature (4 –7 DIV) neurons wild-type PSD-95 or mutant PSD-
95(C3,5S), both fused with GFP. As has been shown previously
(Craven et al., 1999), overexpressed PSD-95–GFP (wild-type)
forms discrete puncta on the dendrites (Fig. 6A,B, wt). Most of
the PSD-95 puncta colocalize with clusters of NMDARs (Fig. 6B,
top panel). On the other hand, the PSD-95(C3,5S)–GFP mutant,
which cannot be palmitoylated (Craven et al., 1999), shows dif-
fuse staining throughout the cell (Fig. 6B, bottom panel, mut).
The level of PSD-95 expression in PSD-95–GFP-transfected neu-
rons was 9 2-fold (measured in n 5 different neurons) that of
endogenous PSD-95 in untransfected cells, as determined by im-
munostaining with a PSD-95 antibody and comparing the signal
intensity of transfected (identified by GFP staining) and nearby
untransfected neurons (Fig. 6A). Overexpression of PSD-95–
GFP wild-type, but not the (C3,5S) mutant, decreased NMDAR
desensitization ( p  0.001 by one-way ANOVA followed by
Bonferroni’s multiple comparisons test), and the effect of PSD-
95–GFP overexpression was abolished by treatment with
2-bromopalmitate before recording (Fig. 6C) (Iss/Ip: PSD-95,
65 2%, n 8; GFP, 50 2%, n 8; control, 45 2%, n 7;
PSD-95 mutant, 46  4%, n  7; PSD-95 with
2-bromopalmitate, 42  3%, n  7). Similar to 14 DIV neu-
rons, latrunculin treatment did not change NMDAR desensitiza-
tion for 4 –7 DIV neurons (Fig. 6C) (Iss/Ip, 44  3%; n  7).
Treatment with 2-bromopalmitate slightly, but not significantly,
increased desensitization compared with other groups (Fig. 6C)
(Iss/Ip, 34 3%; n 7; p 0.05), suggesting that the endogenous
level of PSD-95 interacting with NMDARs was low at this early
stage of development.
To determine whether, under more physiological conditions
(with Ca 2-dependent desensitization intact), overexpression of
PSD-95 can still change the kinetics of NMDAR-mediated re-
sponses, we recorded currents evoked by 100 M NMDA and 30
M glycine in the presence of 2 mM calcium using the nystatin
patch-clamp method. Again, overexpression of PSD-95 signifi-
cantly decreased NMDAR desensitization (Fig. 6D) (Iss/Ip, 47 4
and 34 2% for PSD-95-transfected and control nontransfected
Figure 6. Overexpression of PSD-95 decreases NMDAR desensitization in immature neurons. A, Left, A representative image of a 7 DIV neuron transfected with PSD-95–GFP and stained with
anti-GFP antibody. Middle, The same neuron is shown stained with anti-PSD-95 antibody (arrowhead). An adjacent untransfected neuron (arrow) is also shown. Note that the level of PSD-95 signal
is much higher for the transfected neuron (for quantification, see Results). B, Neurons were transfected with either PSD-95–GFP wild type (wt) or the (C3,5S) mutant (mut) and stained with both
GFP (left) and NR1 (middle) antibodies. Note that the PSD-95 wild type shows punctate staining along the dendrites and many of the puncta colocalize with the NR1 staining (arrow heads), whereas
the (C3,5S) mutant shows only diffuse staining. Scale bars, 10m. White boxes outline regions shown at higher gain directly below each photomicrograph. C, Overexpression in 4 –7 DIV neurons
of PSD-95 wild type decreased NMDAR desensitization compared with overexpression of GFP alone, untransfected (control), overexpression of PSD-95 mutant, overexpression of PSD-95 wild type
treated with 2-bromopalmitate, neurons treated with latrunculin, or neurons treated with 2-bromopalmitate. One-way ANOVA followed by Bonferroni’s multiple comparisons test showed that the
Iss /Ip value for the PSD-95 wild-type group was significantly greater than all other groups (***p 0.001), whereas all the other groups were not significantly different from each other. Recording
conditions were identical to those used in Figure 2 A. D, As in C, 4 –7 DIV neurons transfected with PSD-95 wild type were compared with untransfected neurons of the same age, except that current
responses were evoked by 100M NMDA (30M glycine) in the presence of 2 mM Ca 2, and nystatin perforated-patch recording technique was used (VH of65 mV). **p 0.01.
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group, respectively; n 7 for both groups; p 0.01). Consistent
with a previous study (El-Husseini et al., 2000), overexpression of
PSD-95 did not significantly change the amplitude of the peak
current mediated by NMDARs (PSD-95, 1532 507 pA, n 8;
GFP, 1687  260 pA, n  8; p  0.05). Together, these data
suggest that association of NMDARs with PSD-95 is necessary to
mediate a dramatic decrease in receptor desensitization during
development.
Modulation of NMDAR desensitization by protein
kinase–phosphatase activity
Because PSD-95 associates with a variety of signaling molecules
(Sheng and Pak, 2000), it is possible that its effect was exerted by
recruiting kinases and/or phosphatases to the NMDAR complex,
thereby altering the balance between phosphorylation and de-
phosphorylation of either the NMDAR itself or a closely associ-
ated protein. To test this hypothesis, we examined the effects of
kinases and phosphatases that have been implicated in regulating
NMDAR function.
Glycine-independent desensitization is promoted by cal-
cineurin activity (Lieberman and Mody, 1994; Tong and Jahr,
1994; Tong et al., 1995), an effect that appears as a time-
dependent increase in desensitization associated with prolonged
whole-cell dialysis and an increase in intracellular Ca 2 (Sather et
al., 1992; Tong and Jahr, 1994; Krupp et al., 2002). Using either
the nystatin perforated or conventional whole-cell patch-clamp
recording method, we found that the Iss/Ip ratio was stable over
time for both 4 –7 and13 DIV neurons (Fig. 7A,B), suggesting
that calcineurin did not play a large role in regulating NMDAR
desensitization under our experimental conditions. This result
was not surprising because we used conditions that promoted
maintenance of low intracellular Ca 2, thus minimizing cal-
cineurin activity. In support of this conclusion, application of a
calcineurin inhibitor cyclosporin A (500 nM) for 5–15 min had no
effect on NMDAR desensitization in 4 –7 DIV neurons (Fig. 7C)
(Iss/Ip, 40  3%, n  13 and 40  2%, n  6 for control and
cyclosporin A, respectively; p  0.05). Previous studies also
showed that the effect of calcineurin on NMDAR desensitization
was inhibited by blocking Ca 2 entry (Lieberman and Mody,
1994) and that, under conditions of high intracellular Ca 2 buff-
ering (10 mM EGTA), calcineurin-mediated dephosphorylation
was slow and did not appreciably contribute to fast synaptic
NMDAR desensitization (Raman et al., 1996).
To address further the role of protein phosphorylation in reg-
ulating NMDAR desensitization, we applied a variety of protein
kinase and phosphatase inhibitors–activators to neuronal cul-
tures. For NMDARs in 4 –7 DIV neurons, application of forskolin
(50 M, 5–15 min), a protein kinase A (PKA) activator that aug-
ments NMDAR-mediated responses by overcoming the effect of
calcineurin (Raman et al., 1996), or the PKA inhibitor PKI (Ra-
man et al., 1996), had no effect on Iss/Ip (Fig. 7C). Similarly, a
Ca 2/calmodulin kinase II inhibitor KN93 (10 M, 5–15 min)
and a tyrosine phosphatase inhibitor bpV(phen) (100 M, 5–15
min) had no significant effect on desensitization when control
and all five treatment groups were compared using one-way
ANOVA followed by Bonferroni’s multiple comparisons test
(Fig. 7C) ( p  0.05 for comparison among all groups). On the
other hand, the tyrosine phosphatase inhibitor bpV(phen) re-
sulted in a small decrease in NMDAR desensitization that was
significantly different when compared directly with the control
(vehicle treatment) group alone (Iss/Ip, 49 3%, n 12 and 40
3%, n 13 for bpV(phen) and control groups, respectively; p
0.05; unpaired t test).
Results for mature (13 DIV) neurons were similar to those
of experiments with immature neurons. Treatment of13 DIV
neurons with either the tyrosine kinase inhibitor genistein (50
M, 5–15 min) or Src family tyrosine kinase inhibitor PP2 (10
M, 5–15 min), or KN93, bpV(phen), forskolin, or PKI all failed
to significantly affect NMDAR desensitization, using the one-way
ANOVA followed by Bonferroni’s multiple comparisons test for
all seven groups ( p 0.05) (Fig. 7D). However, incubation with
forskolin resulted in a small increase in NMDAR desensitization
that was significantly different when compared directly with the
control group alone, and its effect was blocked by coincubation
with PKI (Fig. 7D) (Iss/Ip, 77 4%, 65 3%, and 78 3%; n
13, 11, and 7 for control, forskolin, and forskolin plus PKI, re-
spectively; p  0.05 between forskolin and control, or between
forskolin and forskolin plus PKI, by unpaired t test). Coincuba-
tion with bpV(phen) did not block the effect of forskolin on
desensitization (Fig. 7D) [Iss/Ip, 65 3%; n 7; p 0.05 between
forskolin plus bpV(phen) and control; p 0.05 between forsko-
lin alone and forskolin plus bpV(phen)], suggesting that the ef-
fect of forskolin occurred through the activation of PKA and not
Figure 7. NMDAR desensitization is regulated by phosphorylation– dephosphorylation. A,
Desensitization of NMDARs in either 4 –7 or13 DIV neurons was stable over time, suggesting
that calcineurin did not regulate desensitization. Recordings were made using the nystatin
perforated-patch recording technique, with VH of40 mV in the absence of Ca
2. Currents
were evoked by 100M NMDA (30M glycine). Ifenprodil at 10M was included for recordings
from13 DIV neurons. B, Same as A, except that recordings were made using conventional
whole-cell voltage clamp (VH of65 mV) with 10 mM BAPTA in the electrode solution and 0.2
mM external Ca 2 in the absence of ifenprodil, and currents were evoked by 1 mM NMDA (100
M glycine). C, Treatment of 4 –7 DIV neurons with bpV(phen) decreased NMDAR desensitiza-
tion, but treatment with PKI, forskolin, cyclosporin A, or KN93 did not. D, Treatment of13 DIV
neurons with forskolin increased NMDAR desensitization, but treatment with genistein, PP2,
bpV(phen), or KN93 did not. The effect of forskolin was blocked by coincubation with PKI but not
bpV(phen). *p 0.05 versus control group by unpaired t test. Recording conditions in C and D
were identical to those in B.
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via cross-talk between PKA and tyrosine kinases or phosphatases
as proposed by a recent study (Woodward, 2002). Together, these
data indicate that activity of the protein kinases and phosphatases
tested in our experiments cannot account for the dramatic differ-
ence in extent of NMDAR desensitization observed in immature
versus mature neurons.
Discussion
Here, we report a developmental decrease in NMDAR desensiti-
zation that was not dependent on a switch in NMDAR subunit
composition or change in sensitivity to ambient zinc but was
tightly correlated with a change in receptor subcellular localiza-
tion. A major difference between synaptic and extrasynaptic
NMDARs is that the former colocalize and interact with many
signaling proteins that are concentrated within the PSD compart-
ment (Ziff, 1997). Of the many PSD proteins that can potentially
modulate NMDAR properties, PSD-95 has gained the most at-
tention. PSD-95 interacts with the C-terminal ET/SDV sequences
of NMDAR NR2 subunits through its first two PDZ (postsynap-
tic density-95/Discs large/zona occludens-1) domains (Kornau et
al., 1995). In cultured hippocampal neurons, PSD-95 clusters
colocalize with synaptic, but not nonsynaptic, NMDARs (Rao et
al., 1998). The effects of PSD-95 on NMDARs are diverse. For
example, PSD-95 can cluster NMDARs expressed in COS-7 cells
(Kim et al., 1996), couple NMDARs to Src family tyrosine kinases
and thus promote receptor tyrosine phosphorylation (Tezuka et
al., 1999; Liao et al., 2000), couple NMDARs to nitric oxide syth-
ase and thus to nitric oxide toxicity (Sattler et al., 1999), increase
NMDAR expression (Yamada et al., 1999; Rutter and Stephen-
son, 2000), decrease NMDAR sensitivity to glutamate (Yamada et
al., 1999; Rutter and Stephenson, 2000), and inhibit the potenti-
ating effects of PKC and insulin on NMDARs (Yamada et al.,
1999; Liao et al., 2000).
We provide several lines of evidence to suggest that colocal-
ization of PSD-95 with NMDARs can primarily account for the
developmental change in NMDAR desensitization. It is known
that PSD-95 is coclustered with NMDARs primarily at synapses
(Rao et al., 1998), where we showed that NMDARs exhibit little
desensitization. Furthermore, inhibition of palmitoylation in
mature neurons increased NMDAR desensitization. Inhibitors of
PSD-95 palmitoylation have been shown to decrease PSD-95
clusters at synapses and increase diffuse immunostaining of
PSD-95 throughout dendritic shafts and the soma, indicating a
shift from synaptic to nonsynaptic localization and also away
from membranes to the cytoplasm (El-Husseini et al., 2002).
However, NMDARs remain clustered at synapses under these
conditions (El-Husseini et al., 2002), suggesting that NMDARs
and PSD-95 become “uncoupled.” Consistent with this, we
found that inhibition of PSD-95 palmitoylation disrupted the
interaction between NMDARs and PSD-95 assessed by a coim-
munoprecipitation assay. Similarly, chronic PTX treatment of
mature neurons resulted in a decrease in synaptic NMDARs and
dissociation from PSD-95 (Figs. 3, 5) (Crump et al., 2001). Under
these conditions, we found that NMDAR desensitization was in-
creased markedly to levels not significantly different from those
found in immature (4 –7 DIV) neurons. However, because
2-bromopalmitate is a general palmitoylation inhibitor (El-
Husseini et al., 2002), we cannot rule out the possibility that
inhibition of palmitoylation of other PSD proteins may also con-
tribute to the regulation of NMDAR desensitization. Given the
dramatic effect of PSD-95 overexpression in immature neurons,
the contribution from other proteins, if there is any, should be
low. On the other hand, treatment with latrunculin, resulting in
actin depolymerization, causes movement of both NMDARs and
PSD-95 away from synapses, in which the two remain coclustered
(Allison et al., 1998). Consistent with this, latrunculin treatment
of either mature or immature neurons had no effect on NMDAR
desensitization. Finally, when PSD-95 expression was increased
ninefold and observed to colocalize with NMDAR clusters in
transfected immature neurons, NMDAR desensitization was dra-
matically reduced and not significantly different from that found
in mature (13 DIV) neurons. Although NMDAR clusters were
not quantitatively compared between PSD-95-transfected and
control neurons, there was no visually apparent difference in
NMDAR staining pattern between the two groups. The effect of
wild-type PSD-95 overexpression in immature neurons was also
abolished by inhibition of palmitoylation. Also, overexpression
of a mutant PSD-95 that cannot be palmitoylated was ineffective
in changing desensitization, suggesting that palmitoylation and
proper targeting of PSD-95 is important for its regulation of
NMDAR function.
It should be noted that treatments that altered NMDAR de-
sensitization in mature neurons also disrupted association of
PSD-95 and NMDARs by shifting one or both away from syn-
apses rather than changing overall expression levels of PSD-95. It
is interesting that, in a previous study, suppression of PSD-95
protein levels in cultured cortical neurons using an oligonucleo-
tide antisense approach did not result in a change in macroscopic
kinetics of NMDAR-mediated currents (Sattler et al., 1999). It is
possible that those results were attributable to compensation by
other signaling molecules during chronic suppression of PSD-95
expression. Furthermore, treatment of cultured hippocampal
neurons with a peptide to disrupt interaction of PSD-95 and
NR2B did not alter the time course or amplitude of the NMDA-
evoked calcium response (Aarts et al., 2002). However, because
the interaction between NR2A and PSD-95 remained intact un-
der those conditions (Aarts et al., 2002), and because NR2A is
preferentially targeted to synapses, NMDAR–PSD-95 interac-
tions would have remained primarily intact at synapses, and
therefore no increase in desensitization would be expected.
NMDARs in 4 –7 DIV neurons are mostly extrasynaptic and
do not interact with PSD-95. Overexpression of PSD-95 in those
neurons may regulate NMDAR desensitization by recruiting ty-
rosine kinases and promoting tyrosine phosphorylation of
NMDARs (Tezuka et al., 1999; Liao et al., 2000). This is sup-
ported by the fact that inhibition of tyrosine phosphatase activity
by bpV(phen) decreased NMDAR desensitization in 4 –7 DIV
neurons (Fig. 7C). Consistently, bpV(phen) also decreased the
desensitization of recombinant NMDARs expressed in HEK293
cells (Krupp et al., 2002). It must be emphasized, however, that an
altered balance of tyrosine phosphorylation attributable to
PSD-95 recruitment of protein tyrosine kinases may not fully
explain the difference in NMDAR desensitization between im-
mature and mature neurons, because this difference is large com-
pared with the effect of tyrosine phosphatase inhibition on
NMDAR desensitization in immature neurons. In addition, de-
sensitization of NMDARs in 13 DIV neurons was not influ-
enced by incubation with either PP2 or genistein, agents that
inhibit tyrosine kinases, suggesting that synaptic NMDARs are
resistant to tyrosine dephosphorylation or else that factors other
than tyrosine kinases–phosphatases contribute to regulation of
NMDAR desensitization in mature neurons versus immature
neurons.
PSD-95 can also induce the assembly of signaling molecules
other than tyrosine kinases in the PSD to regulate synaptic
NMDAR function. For example, PKA is targeted to NMDARs via
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an interaction between PSD-95 and AKAP (A-kinase anchoring
protein) (Colledge et al., 2000), and we found that activation of
PKA by forskolin resulted in a small increase in desensitization of
NMDARs in13 DIV neurons. This effect of PKA was somewhat
surprising, because previous studies indicate that PKA activation
can overcome the effects of calcineurin (Raman et al., 1996) and
prevent the calcineurin-dependent increase in desensitization
(Krupp et al., 2002). However, the effects of PKA on NMDAR
function are complicated; both upregulation (Blank et al., 1997;
Westphal et al., 1999) and downregulation (Woodward, 2002) of
NMDAR function have been reported. Moreover, mutation in
NR2A of putative phosphorylation sites serine 900 (S900A) and
serine 929 (S929A) resulted in an increase and decrease of desen-
sitization, respectively (Krupp et al., 2002). These studies suggest
that phosphorylation of NR2A by PKA at different sites can have
opposite effects. Notably, we found that PKA or its inhibitor did
not regulate NMDAR desensitization in 4 –7 DIV neurons, in
which the large majority of NMDARs are extrasynaptic. This may
be explained by recent studies showing that regulation of gluta-
mate receptors by PKA requires targeting of PKA to the receptors
by “bridging” proteins, including yotiao, PSD-95/AKAP, and
SAP97 (synapse-associated protein 97)/AKAP, all of which are
enriched in the PSD (Lin et al., 1998; Westphal et al., 1999; Col-
ledge et al., 2000).
A developmental change in the decay of single NMDAR-
mediated synaptic responses has been reported to depend on a
switch in subunit composition (Carmignoto and Vicini, 1992;
Hestrin, 1992; Monyer et al., 1994; Flint et al., 1997). Here we
showed that decay of whole- cell NMDAR current in response to
sustained activation is also regulated developmentally, and this
change is associated with recruitment of NMDARs to synapses
during development. We reported previously that the activity of
extrasynaptic NMDARs is more readily downregulated through a
process called rundown compared with synaptic NMDARs (Li et
al., 2002). Together with the current findings, our results indicate
that NMDAR function within a single neuron is fine-tuned on
the basis of receptor subcellular localization. Thus, synaptic
NMDAR activity, which is resistant to downregulation by either
rundown or desensitization, can maintain high-fidelity transmis-
sion at synapses to fulfill its role in synaptic plasticity during
repetitive firing. Activity of extrasynaptic NMDARs, on the other
hand, is readily shut down by desensitization and/or rundown to
limit neuronal damage during pathological conditions such as
ischemia, in which sustained glutamate release and spillover can
occur. Differential regulation of synaptic and nonsynaptic
NMDAR activity may, in part, underlie the different roles these
two groups of receptors play in excitotoxicity (Sattler et al., 1999;
Hardingham et al., 2002).
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